Status:
COMPLETED
A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence
Lead Sponsor:
FemmePharma Global Healthcare, Inc.
Conditions:
Urinary Incontinence, Urge
Eligibility:
FEMALE
18-75 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the safety of three doses of oxybutynin for the treatment of urge urinary incontinence.
Eligibility Criteria
Inclusion
- Females 18 to 75 years of age
- Has reported symptoms of urge urinary incontinence/overactive bladder
Exclusion
- Is pregnant or lactating
- Has had lower urinary tract surgery within 6 months prior to Screening
- Has a history of urinary retention
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00749632
Start Date
July 1 2007
End Date
October 1 2008
Last Update
October 15 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
SNBL Clinical Pharmacology Center
Baltimore, Maryland, United States, 21201
2
Advanced Biomedical Research
Hackensack, New Jersey, United States, 07601